Why settle for tech transfer when you can sell direct?
Published September 13, 2024
At the Special Edition Virtual Pub, “Innovation in Imaging,” we will discuss some of the issues that innovators should be aware of and hear use cases from our network about successful tech transfer and translation from the lab.
When: September 27, 2024, from 13:00-15:30 CEST
Where: Online
At this event, Ed Mitchell (ESRF), will explore the pros and cons of internal approach to technology development and manufacturing in a presentation entitled, “Why settle for tech transfer when you can sell direct?”
WhY SETTLE FOR TECh transfer when you can sell direct?
Ed Mitchell, ESRF
Abstract
In today’s rapidly evolving innovation landscape, research institutions can face a critical decision: should they transfer their technology to external partners or develop and commercialise it internally? An internal approach can maximise financial returns and visibility of the facility concerned, but involves manufacture of the products in-house with the risks and effort that this requires. This presentation will be a rapid perspective on the pros and cons of bypassing traditional technology transfer and adopting an in-house development and commercialization approach, leveraging facility expertise and resources to directly bring products to market.
More news from Euro-BioImaging
